| Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. BI Posner, R Faure, JW Burgess, AP Bevan, D Lachance, G Zhang-Sun, ... Journal of Biological Chemistry 269 (6), 4596-4604, 1994 | 659 | 1994 |
| Leishmania‐induced increases in activation of macrophage SHP‐1 tyrosine phosphatase are associated with impaired IFN‐γ‐triggered JAK2 activation J Blanchette, N Racette, R Faure, KA Siminovitch, M Olivier European journal of immunology 29 (11), 3737-3744, 1999 | 260 | 1999 |
| The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis MJ Dubois, S Bergeron, HJ Kim, L Dombrowski, M Perreault, B Fournès, ... Nature medicine 12 (5), 549-556, 2006 | 181 | 2006 |
| Modulation of interferon-γ-induced macrophage activation by phosphotyrosine phosphatases inhibition: effect on murine leishmaniasis progression M Olivier, BJ Romero-Gallo, C Matte, J Blanchette, BI Posner, ... Journal of Biological Chemistry 273 (22), 13944-13949, 1998 | 180 | 1998 |
| The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase (s). R Faure, G Baquiran, JJ Bergeron, BI Posner Journal of Biological Chemistry 267 (16), 11215-11221, 1992 | 156 | 1992 |
| Peroxovanadium‐mediated protection against murine leishmaniasis: role of the modulation of nitric oxide C Matte, JF Marquis, J Blanchette, P Gros, R Faure, BI Posner, M Olivier European Journal of Immunology 30 (9), 2555-2564, 2000 | 107 | 2000 |
| Activation of HIV-1 long terminal repeat transcription and virus replication via NF-κB-dependent and-independent pathways by potent phosphotyrosine phosphatase inhibitors, the … B Barbeau, R Bernier, N Dumais, G Briand, M Olivier, R Faure, BI Posner, ... Journal of Biological Chemistry 272 (20), 12968-12977, 1997 | 103 | 1997 |
| Regional distribution of nuclear T3 receptors in rat brain and evidence for preferential localization in neurons1 J Ruel, R Faure, JH Dussault Journal of endocrinological investigation 8, 343-348, 1985 | 102 | 1985 |
| Arrest at the G2/M transition of the cell cycle by protein‐tyrosine phosphatase inhibition: Studies on a neuronal and a glial cell line R Faure, M Vincent, M Dufour, A Shaver, BI Posner Journal of cellular biochemistry 59 (3), 389-401, 1995 | 90 | 1995 |
| Interspecific Variation in Terpenoid Composition of Defensive Secretions of European Reticulitermes Termites A Quintana, J Reinhard, R Faure, P Uva, AG Bagnères, G Massiot, ... Journal of chemical ecology 29, 639-652, 2003 | 87 | 2003 |
| Human vascular endothelial cells with extended life spans: In vitro cell response, protein expression, and angiogenesis E Gagnon, P Cattaruzzi, M Griffith, L Muzakare, K LeFlao, R Faure, ... Angiogenesis 5, 21-33, 2002 | 64 | 2002 |
| Identification of the proteins present in the bull sperm cytosolic fraction enriched in tyrosine kinase activity: a proteomic approach C Lalancette, RL Faure, P Leclerc Proteomics 6 (16), 4523-4540, 2006 | 61 | 2006 |
| Hepatic protein phosphotyrosine phosphatase. Dephosphorylation of insulin and epidermal growth factor receptors in normal and alloxan diabetic rats. PA Gruppuso, JM Boylan, BI Posner, R Faure, DL Brautigan The Journal of clinical investigation 85 (6), 1754-1760, 1990 | 54 | 1990 |
| Ontogenesis of nuclear T3 receptors in primary cultured astrocytes and neurons M Luo, R Faure, JH Dussault Brain research 381 (2), 275-280, 1986 | 44 | 1986 |
| A novel mutation in the EIF2AK3 gene with variable expressivity in two patients with Wolcott–Rallison syndrome F Durocher, R Faure, Y Labrie, L Pelletier, I Bouchard, R Laframboise Clinical genetics 70 (1), 34-38, 2006 | 43 | 2006 |
| Keratin 8/18 regulation of glucose metabolism in normal versus cancerous hepatic cells through differential modulation of hexokinase status and insulin signaling J Mathew, A Loranger, S Gilbert, R Faure, N Marceau Experimental cell research 319 (4), 474-486, 2013 | 41 | 2013 |
| A monoclonal antibody to the rat nuclear triiodothyronine receptor: production and characterization MIN LUO, R FAURE, J RUEL, JH DUSSAULT Endocrinology 123 (1), 180-186, 1988 | 40 | 1988 |
| Hyperoxia induces S-phase cell-cycle arrest and p21Cip1/Waf1-independent CDK2 inhibition in human carcinoma T47D-H3 cells JF Bilodeau, R Faure, B Piedboeuf, ME Mirault Experimental cell research 256 (2), 347-357, 2000 | 37 | 2000 |
| The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in … M Boutchueng-Djidjou, G Collard-Simard, S Fortier, SS Hébert, I Kelly, ... Molecular & Cellular Proteomics 14 (4), 1079-1092, 2015 | 33 | 2015 |
| Protein tyrosine phosphatase inhibition induces anti-tumor activity: evidence of Cdk2/p27kip1 and Cdk2/SHP-1 complex formation in human ovarian cancer cells D Caron, PE Savard, CJ Doillon, M Olivier, E Shink, JG Lussier, RL Faure Cancer letters 262 (2), 265-275, 2008 | 33 | 2008 |
John BergeronProfessor, McGill UniversityVerified email at mcgill.ca
